Outlook Therapeutics, Inc. (OTLK) KPIs and segments
OTLKNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
$0.36−0.04 (-8.94%)
Close on Nov 17, 2026Market cap $87.79MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Outlook Therapeutics's business
Coming soon
This tab will track the numbers specific to Outlook Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?